Breaking News
March 22, 2018 - Researchers explain link between 2 key Alzheimer’s proteins
March 22, 2018 - Patients on replacement therapy with thyroid hormone may have more comorbidities
March 22, 2018 - Higher online patient ratings linked to urologists who saw fewer Medicare patients
March 22, 2018 - FDA Approves Ilumya (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
March 22, 2018 - Beer Raises Heart Rate; KardiaBand Hyperkalemia Test; CHD Clinics
March 22, 2018 - A retinal implant that is more effective against blindness
March 22, 2018 - New system based on artificial intelligence provides reliable detection of breast cancer
March 22, 2018 - Research offers new understanding about cause of Parkinson’s disease
March 22, 2018 - HORIBA’s Microsemi CRP analyzer improves quality of care in emergency pediatric units, study shows
March 22, 2018 - Range of Vaginal Dryness Products Can Help Postmenopausal Women: Study
March 22, 2018 - Higher Dose Tx Deemed Safe in Pulmonary TB
March 22, 2018 - Discovery of new ALS gene points to cytoskeleton as potential target for drug development
March 22, 2018 - Diet soda associated with higher odds of diabetic retinopathy
March 22, 2018 - LSD reduces ‘sense of self’
March 22, 2018 - Vitamin D deficiency linked to metabolic syndrome in postmenopausal women
March 22, 2018 - Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery
March 22, 2018 - iPads and Cancer; Clot Retrieval and Stroke: It’s PodMed Double T!
March 22, 2018 - Premature births linked to changes in mother’s bacteria
March 22, 2018 - Brain SPECT scans predict treatment outcomes in patients with depression
March 21, 2018 - Researchers succeed in integrating artificial organelles into cells of living organism
March 21, 2018 - Researchers discover ‘missing mutation’ in severe infant epilepsy
March 21, 2018 - Researchers develop statistics-based computational scheme to zoom in on brain function
March 21, 2018 - Verge joins Genomics England’s Discovery Forum industry partnership
March 21, 2018 - Trovagene Announces First Patient Successfully Completes Cycle 1 of Treatment with PCM-075 in Combination with Low Dose Cytarabine (LDAC) in AML Trial
March 21, 2018 - Congenital Cardiac Cath Tx Often Strays from Guidelines
March 21, 2018 - Marked increase in cardiovascular risk factors in women after preeclampsia
March 21, 2018 - New app may help predict, track manic and depressive episodes in bipolar patients
March 21, 2018 - Discovery of genes could lead to development of novel therapies for EBV-related cancers
March 21, 2018 - High-fat, high-cholesterol diet depletes ranks of artery-protecting immune cells
March 21, 2018 - Research misconduct allegations shadow likely CDC appointee
March 21, 2018 - Most Breast Ca Patients Fail to Get Genetic Counseling
March 21, 2018 - Lopsided ear function can lead to lopsided brain development
March 21, 2018 - Acupuncture helps manage menopausal symptoms, review finds
March 21, 2018 - Motor skill training may contribute to reading skills in obese children
March 21, 2018 - Poor dental health may be related to increased diabetes risk
March 21, 2018 - Chronic opioid users at increased risk of complications after spinal fusion surgery
March 21, 2018 - Study uncovers potential therapeutic target against large family of parasites
March 21, 2018 - NSAID use linked to increased risk of atrial fibrillation
March 21, 2018 - Scientists develop brain “stethoscope” that can detect silent seizures
March 21, 2018 - New method predicts effects of global warming on disease
March 21, 2018 - Insurance Company Hurdles Burden Doctors, May Harm Patients
March 21, 2018 - Renal Transplant from HCV-Positive Donors Feasible
March 21, 2018 - Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
March 21, 2018 - Research reveals brain mechanism involved in language learning
March 21, 2018 - Many parents still hesitate to try early peanut introduction, survey finds
March 21, 2018 - Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
March 21, 2018 - Study reveals impact of prostate cancer on wives and partners of sufferers
March 21, 2018 - ‘Almost a Miracle Drug’: What We Heard This Week
March 21, 2018 - Study shows NIH spent >$100 billion on basic science for new medicines
March 21, 2018 - Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
March 21, 2018 - Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
March 21, 2018 - Increase in coffee consumption may help battle against colon cancer
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
WPI professor receives Smith Family Foundation grant to explore biology of cancer cells

WPI professor receives Smith Family Foundation grant to explore biology of cancer cells

image_pdfDownload PDFimage_print

Amity Manning, assistant professor of biology and biotechnology, has received a three-year, $300,000 award from the Smith Family Awards Program for Excellence in Biomedical Research. The grant will support her research on the molecular biology of cancer cells, work that may lead to a better understanding of how tumors evolve and how some become resistant to chemotherapy drugs–knowledge that could pave the way for new kinds of anti-cancer medications.

The awards program was established in 1991 by the Richard and Susan Smith Family Foundation, which works to effect permanent change in the lives of residents of Greater Boston. The program helps launch the careers of newly independent faculty members in Massachusetts whose research focuses on biomedicine, with the aim of achieving medical breakthroughs in such areas as cancer, heart disease, diabetes, and neuroscience. Manning is one of just six recipients of the prestigious award this year.

In her research, Manning explores the biology of cancer cells, looking in particular at molecules that help regulate changes in the genome, or genetic material, within these cells. It is known that certain mutations and other defects in the genome are responsible for the uncontrolled cell division that occurs in cancer, for the ability of tumors to adapt to changes in their environment and to metastasize, and for the resistance that some cancers develop to anti-cancer medications. But there are a host of unanswered question about how those genetic changes occur and the effect they have on cancer cells.

Manning’s current focus is a molecule known as retinoblastoma protein, or pRB. In normal tissue, pRB helps determine when cells can divide. In tumor cells, the protein is either defective or not present, which leads to uncontrolled cell division. In previous work, funded by the National Institutes of Health, Manning and her research team showed that pRB also plays a role in assuring that the chromosomes are correctly segregated when a cell divides.

During normal cell division, or mitosis, a human cell’s 46 chromosomes are first duplicated, then the pairs of duplicates line up in the center of the cell. Thin fibers called microtubules emerge from structures known as centromeres and pull the duplicate sets of chromosomes apart so two new “daughter” cells, each with an identical set of chromosomes, can be formed.

In the absence of normally functioning pRB, the segregation process goes awry. As a result, the daughter cells can end up with the wrong number of chromosomes (known as aneuploidy). In her research, Manning has found that the absence of pRB is associated with defects in chromatin, the complex of proteins and genetic material that make up chromosomes. These defects may alter the way microtubules latch onto and move the chromosomes.

Errors in chromosome segregation, known as chromosome instability, are associated with genetic differences that are seen between tumors of the same type, and even between cells within the same tumor. They may also contribute to the increasing number of mutations that can occur as a tumor grows. The resulting genetic heterogeneity is believed to account for the fact that a tumor that responds well to chemotherapy may later become resistant to the anticancer drugs.

“We believe chromosome instability plays a role in the heterogeneity we see within tumors,” Manning says, “and that heterogeneity is linked to the ability to acquire drug resistance. Because the cells within a tumor are genetically different, a drug that kills one of the daughters of a cell division may not be sufficient to kill the other. And because cancer cells proliferate so quickly, a tumor will quickly generate more and more copies of the resistant cell. It’s a moving target.”

With the funding from the Smith Foundation, Manning hopes to learn more about how pRB helps regulate chromosome segregation in normal cells to better understand what doesn’t happen or what happens differently when pRB not functional. This knowledge may help identify targets for new medications that could prevent segregation errors and assure that the chromosomes separate accurately. “Since all progeny will then be identical,” Manning says, “all the cells of the tumor may remain similarly sensitive to therapy and drug resistance will be limited.”

Manning said she believes her research will show that pRB plays a multifaceted role in regulating chromosome segregation, one that likely involves recruiting proteins that regulate the organization of DNA. Changes in the activity of such regulators are known as epigenetic changes; they can impact what genes are expressed and how chromatin behaves, without altering the DNA sequences. “We believe that pRB functions as a sort of scaffold,” Manning said. “It brings the other regulators to the genome and those regulators determine how the chromatin of organized. So when pRB is not there, those regulators are not recruited the way they should be.

“We want to look at which of those regulators might be altered and if there are specific regions of the genome that are most sensitive to changes in those alterations when pRB is absent. And then, hopefully, if we can identify those changes, we can try to understand, functionally, how they are involved in cell division.”

Manning said her team will be looking closely at changes that affect the centromere. “The centromere is the functional region of the chromosome that is important for attachments to microtubules and proper segregation. We think pRB is particularly important in recruiting regulators to the centromere, such that the absence of pRB may cause defects in centromere structure, which would alter how microtubules attach and lead to errors in chromosome segregation.”

Unlike mutations and other genetic alterations, these epigenetic changes are reversible, Manning said. “If we can show that the absence of pRB results in changes in the way that chromatin structure is regulated, we may also be able to show how those changes can be reversed. To me, that is one of the most exciting aspects of this work.”​​


Tagged with:

About author

Related Articles